The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Our little has been covered in the Telegraph http://www.telegraph.co.uk/business/2017/12/14/sanjeev-gupta-takes-first-step-london-stock-exchange-renewable/
Whatever the short -term effect of a placing - and I think it may only be a very short-term dip - today's release sounds like one very self-confident rns and one very busy and ambitious company. There would seem to be major developments in at least two of our three markets in the next few months - this feels like a great time to get on board.
Well somebody's sell-off is continuing apace this afternoon - do people think a further statement of some sort from the company might help? Or maybe a better policy is to sit tight and keep quiet while the seller sells. I'm maxed out here but what a brilliant opportunity for anyone sniffing around looking for a bargain. Yes we may two years from profitability but as has been said there's plenty of reasons to think the figures will be looking better and better into the new year.
Gosh it all gets murkier(see today's RNS). And what a magnificent name for a villain - Bismarck Badilla. He looks a right wideboy as well. Looks like we'll have to rely on the Swiss regulatory system to get our money back. Perhaps they could sell some of that Nazi gold...(allegedly etc...)
It certainly tests the patience - I got in at 14, saw it rise to 30, and now it is what it is. I'll take the hit and stay in because I only ever invest what I'm prepared to lose and despite the prolonged nose dive I still feel there's hope here. Just hope the new senior management are able to stabilise and push on.
So we've cut costs and are trading profitably, but we *may* have been stiffed for �750k, though the payment is only a few days late and we've "no reason to think" it won't be paid. They'll let us know soon. Given there's currently a 9 per cent drop showing, sounds a nice little binary play for those in the mood.
So this most recent nasty drop is clearly linked to the uncertainty of losing a CEO. I wish we knew more about that scenario but obviously it is not about to be shared with us. It all seemed to happen very quickly and they don't appear to have anyone lined up, so that presumably means a full recruitment process, which I suppose could take three months to get someone in place. Looking for an ideal outcome though we get a high quality leader in within two weeks who can make the most of the huge potential of the new merged company, and the market will get back on board with us. If the company keeps stable there's no reason why the good news flow shouldn't start in earnest within a year and we'll be basking in the sunlit uplands by 2020.
Well looks like a few people knew this yesterday. Not remotely qualified to comment on this, but also yesterday my football club sacked our manager - despite watching the club every week I can't be sure it's the right move, I just have to sit back and hope the board get the next appointment right. I suppose that's what I have to do with TRX. Guus Hiddink would do (for City, not TRX ;-)
I think I'm staying and I was 100 per cent up at one point. It is depressing, but I wonder if the current fall is about that impatience that hits companies at this stage in their development - the science is proved, the sales force is in place, first sales come in - some investors want money to be made right away, but then they discover it's another three years before any profit is made. We've been through the 'excitement about potential' phase, we're now still in the spend, spend, spend phase and progress is solid rather spectacular. It'll be 2020 before we approach 'coining it in' phase but I still think it will come.
Yes - though of course there's an awful lot that should happen for the company and the share price by then. I don't think that prospect should affect any investment decisions now - at 11p this is still very cheap regardless of a potential share issue which would amount to one year's working capital to see us through to profitability.
A nasty little drop through the floor, on very little volume, 2/3 days before results. Can some wise person tells us what that's likely to mean - someone knows some bad news? Someone knows some good news but has successfully manipulated to price down and will buy a few more by tomorrow evening? No-one really knows very much and it's just the kind of thing that happens while we were waiting for news?
Snippy piece in the FT today suggesting XSG ("Xeros needs to dry up" - geddit?) shouldn't have released yesterday's info because there was no name, no money changing hands and no commercialisation contracts signed. Therefore it could have waited for next weeks half yearly figures and now we just sound like we're ramping ourselves. XSG should "learn the benefits of keeping its powder dry". Hmmm - as I suggested we yesterday I think we are aware this is not a huge game-changing moment, but it is significant progress and I'm glad to know as soon as it happened.
Excellent - today's news may not be the big one, but it's an important staging post to the big one. We've got an agreement signed with a major manufacturer to integrate out technology in their machine and as long as the product development doesn't hit a bump in the road, we could start seeing regular income from them in the not too distant future. Probably a few months ahead of my expectations now.
So, according to this evening's RNS we may now be entering the end game for the Touchstone takeover with 90 per cent accepting or indicating they will accept the offer. A good time then to announce a boots-filling incentive for senior staff in another RNS.. Let's hope we see an upwardly mobile SP sooner rather than later and we can all get excited about the great work of this fund.
I think it's clear the current doldrums are mainly about the volatile state of the takeover and this troubled fundraising from the Chinese. Our portfolio is compelling - I'm convinced several will come good bigstyle in the next couple of years - but that doesn't seem to have as much impact on the sp as the current wrangling. So basically what I'm saying is, there there, it'll be alright in the end.
About time too. I wonder what's behind this - news brewing on merger maybe but with a company like this could be anything with one of our portfolio companies. TRX is staging a little comeback but I suspect there's more going on.
As always seems to happen I did miss out on the bottom price, but have brought a few more @13p and I'm very confident that is still a good price in the short, medium and long term. I thought this anyway but the Hardman research makes a very compelling case for the synergy with Cellright speeding up our growth and progress towards profitability by 2020. Still annoyed at paying 3p more than then placing but focusing on the bigger picture ;-).
How lovely to see a bit of positive action just before the weekend. Woodford's words are obviously welcome but let's just remember this is the Patient Capital fund - do think it can rise slowly over coming months, but multi-bagging? Let's have a look this time next year.